Last reviewed · How we verify
Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer
The purpose of this study to find out whether a very low carbohydrate diet (ketogenic diet), a low carbohydrate diet, or the study drug canagliflozin can prevent high blood sugar and may improve the effectiveness of cancer therapy in people who are receiving standard treatment with alpelisib and fulvestrant for their metastatic PIK3CA-mutant breast cancer.
Details
| Lead sponsor | Memorial Sloan Kettering Cancer Center |
|---|---|
| Phase | PHASE2 |
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 15 |
| Start date | Fri Oct 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Oct 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Breast Cancer
- Breast Cancer Stage IV
- Metastatic Breast Cancer
Interventions
- Ketogenic Diet
- Low Carbohydrate Diet
- Alpelisib
- Fulvestrant
- Canagliflozin
Countries
United States